로딩 중…
지수 로딩 중…
CG Oncology, Inc. Common stock
CGON· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$61.08+1.08%
2026-06-18
Price Chart
CG Oncology, Inc. Common stock+132.42%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.39B |
| Revenue | $5M |
| Net Income | $-187M |
| Total Assets | $1.14B |
| Net Assets | $1.09B |
| Value | |
| P/B | 4.93x |
| FCF Yield | -2.98% |
| Profitability | |
| ROE | -17.10% |
| ROA | -16.45% |
| Op. Margin | -4238.99% |
| Revenue Growth | 1982.69% |
| Financial Health | |
| Debt Ratio | 3.98% |
| Total Debt | $8M |
| FCF | $-160M |
| Cash | $34M |
| Current Ratio | 31.30x |
| Performance | |
| 1Y Return | 132.42% |
| 1M Return | -3.51% |
| From 52W High | -19.10% |
| 1Y MDD | -27.41% |
| Trading | |
| Volume | 1,799,782 shares |
| Trading Value | $111M |
| Per Share | |
| EPS | $-2.08 |
| BPS | $9.74 |